What Is the True Cost of Lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing?
Unfair Gaps methodology documents how lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing drains medical and diagnostic laboratories profitability.
Lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing is a cost of poor quality in medical and diagnostic laboratories: Lack of barcoded or RFID specimen IDs tied to each movement; missing temperature and time‑in‑transit monitoring; customs or courier interventions where blocks or tubes are removed and not replaced; no. Loss: $50–$200 per affected case (recollection visit, staff time, shipping and test repeat) and easily $100,000+ per year for large labs given frequent redr.
Lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing is a cost of poor quality in medical and diagnostic laboratories. Unfair Gaps research: Lack of barcoded or RFID specimen IDs tied to each movement; missing temperature and time‑in‑transit monitoring; customs or courier interventions where blocks or tubes are removed and not replaced; no. Impact: $50–$200 per affected case (recollection visit, staff time, shipping and test repeat) and easily $100,000+ per year for large labs given frequent redr. At-risk: International or cross‑border send‑outs subject to customs inspection, where components can be remov.
What Is Lost, misrouted, or compromised send‑out specimens and Why Should Founders Care?
Lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing is a critical cost of poor quality in medical and diagnostic laboratories. Unfair Gaps methodology identifies: Lack of barcoded or RFID specimen IDs tied to each movement; missing temperature and time‑in‑transit monitoring; customs or courier interventions where blocks or tubes are removed and not replaced; no. Impact: $50–$200 per affected case (recollection visit, staff time, shipping and test repeat) and easily $100,000+ per year for large labs given frequent redr. Frequency: daily.
How Does Lost, misrouted, or compromised send‑out specimens Actually Happen?
Unfair Gaps analysis traces root causes: Lack of barcoded or RFID specimen IDs tied to each movement; missing temperature and time‑in‑transit monitoring; customs or courier interventions where blocks or tubes are removed and not replaced; no integrated audit trail for outsourced tests.[1][2][4][5]. Affected actors: Quality managers, Laboratory technologists, Phlebotomy supervisors, Reference lab liaisons, Nursing units and outpatient clinic staff. Without intervention, losses recur at daily frequency.
How Much Does Lost, misrouted, or compromised send‑out specimens Cost?
Per Unfair Gaps data: $50–$200 per affected case (recollection visit, staff time, shipping and test repeat) and easily $100,000+ per year for large labs given frequent redraws and repeats on send‑outs reported in quality p. Frequency: daily. Companies addressing this proactively report significant savings vs reactive approaches.
Which Companies Are Most at Risk?
Unfair Gaps research identifies highest-risk profiles: International or cross‑border send‑outs subject to customs inspection, where components can be removed and not returned[2], Specimens requiring strict temperature control (molecular, histology blocks,. Root driver: Lack of barcoded or RFID specimen IDs tied to each movement; missing temperature and time‑in‑transit.
Verified Evidence
Cases of lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing in Unfair Gaps database.
- Documented cost of poor quality in medical and diagnostic laboratories
- Regulatory filing: lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing
- Industry report: $50–$200 per affected case (recollection visit, st
Is There a Business Opportunity?
Unfair Gaps methodology reveals lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing creates addressable market. daily recurrence = recurring revenue. medical and diagnostic laboratories companies allocate budget for cost of poor quality solutions.
Target List
medical and diagnostic laboratories companies exposed to lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing.
How Do You Fix Lost, misrouted, or compromised send‑out specimens? (3 Steps)
Unfair Gaps methodology: 1) Audit — review Lack of barcoded or RFID specimen IDs tied to each movement; missing temperature; 2) Remediate — implement cost of poor quality controls; 3) Monitor — track daily recurrence.
Get evidence for Medical and Diagnostic Laboratories
Our AI scanner finds financial evidence from verified sources and builds an action plan.
Run Free ScanWhat Can You Do With This Data?
Next steps:
Find targets
Exposed companies
Validate demand
Customer interview
Check competition
Who's solving this
Size market
TAM/SAM/SOM
Launch plan
Idea to revenue
Unfair Gaps evidence base.
Frequently Asked Questions
What is Lost, misrouted, or compromised send‑out specimens?▼
Lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing is cost of poor quality in medical and diagnostic laboratories: Lack of barcoded or RFID specimen IDs tied to each movement; missing temperature and time‑in‑transit monitoring; customs.
How much does it cost?▼
Per Unfair Gaps data: $50–$200 per affected case (recollection visit, staff time, shipping and test repeat) and easily $100,000+ per year for large labs given frequent redr.
How to calculate exposure?▼
Multiply frequency by avg loss per incident.
Regulatory fines?▼
See full evidence database for regulatory cases.
Fastest fix?▼
Audit, remediate Lack of barcoded or RFID specimen IDs tied to each movement;, monitor.
Most at risk?▼
International or cross‑border send‑outs subject to customs inspection, where components can be removed and not returned[2], Specimens requiring strict.
Software solutions?▼
Integrated risk platforms for medical and diagnostic laboratories.
How common?▼
daily in medical and diagnostic laboratories.
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Get financial evidence, target companies, and an action plan — all in one scan.
Sources & References
Related Pains in Medical and Diagnostic Laboratories
Technologist and coordinator time wasted searching for and reconciling send‑out specimens
Provider and patient dissatisfaction from inability to give accurate status on send‑out tests
Lost charge capture for send‑out tests due to poor tracking and order/result mismatches
Excess courier, shipping, and labor costs from inefficient send‑out specimen tracking
Delayed billing and extended AR from slow send‑out status visibility
Chain-of-custody and traceability deficiencies risking CLIA/ISO nonconformities for send‑outs
Methodology & Limitations
This report aggregates data from public regulatory filings, industry audits, and verified practitioner interviews. Financial loss estimates are statistical projections based on industry averages and may not reflect specific organization's results.
Disclaimer: This content is for informational purposes only and does not constitute financial or legal advice. Source type: Open sources, regulatory filings.